(Q46647803)

23 December 2017

title

Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan (English)

1 reference

23 December 2017

author name string

Brade V

series ordinal

1

1 reference

23 December 2017

Vogt W

series ordinal

2

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 August 1971

1 reference

23 December 2017

European Journal of Immunology

published in

1 reference

23 December 2017

volume

1

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

295-300

1 reference

23 December 2017

Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Anaphylatoxin in its relation to the complement system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Studies on the relation between the fifth component of complement and anaphylatoxinogen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Interactions of the complement system with endotoxic lipopolysaccharides in immunoglobulin-deficient sera

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Anaphylatoxin formation by contact activation of plasma. I. Activation by zymosan without participation of antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

An alternative mechanism for the properdin system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

The properdin system and immunity. III. The zymosan assay of properdin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Separation, purification and properties of two proteins from rat serum which are essential for anaphylatoxin formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Formation of anaphylatoxin in rat plasma, a specific enzymic process

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Limiting factors of the anaphylatoxin forming system in plasma from different species

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010416

7 January 2021

Identifiers

DOI

10.1002/EJI.1830010416

1 reference

23 December 2017

1 reference

23 December 2017